Selected Grants
The COVID-19 and Cancer Consortium (CCC19) Registry
ResearchAnalyst · Awarded by Rhode Island Hospital · 2024 - 2029A Phase 1b/2 Study Evaluating the Activity of Tinengotinib (TT-00420) in Combination with Androgen Receptor Signaling Inhibitors (ARSIs) in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Clinical TrialPrincipal Investigator · Awarded by Memorial Sloan-Kettering Cancer Center · 2025 - 2029Kidney Cancer Research Program Clinical Consortium Duke University Clinical Trial Site Award
ResearchCo Investigator · Awarded by Department of Defense · 2024 - 2028IRONMAN: ENHANCING SURVIVORSHIP IN MEN WITH ADVANCED PROSTATE CANCER
ResearchJunior Faculty · Awarded by Harvard T.H. Chan School of Public Health · 2023 - 2026External Relationships
- Astellas Pharma Inc.
- Bayer
- Pfizer
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.